ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Study show’s REVERSED aging!
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="BigTex" data-source="post: 261591" data-attributes="member: 43589"><p>Here is the study</p><p></p><p>[URL unfurl="true"]https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028[/URL]</p><p></p><p>Dosing</p><p></p><p style="margin-left: 20px"><em>During the <strong>first week</strong> of the trial, <strong>rhGH alone (0.015 mg/kg</strong>) was administered to obtain an initial insulin response, and during the <strong>second week, rhGH was combined with 50 mg DHEA</strong> to evaluate insulin suppression by DHEA alone. During the <strong>third week, the same doses of rhGH and DHEA were combined with 500 mg metformin</strong>. Beginning at the <strong>fourth week, all doses were individualized based on each volunteer's particular responses</strong>. Thereafter, blood was collected one week prior to trial months 2, 3, 4, 6, and 9 to enable further dose adjustments at those time points (to maximize IGF-1 and minimize insulin), and additional blood samples were obtained at 12 months to conclude the treatment monitoring period. Dosing compliance was verified by the response of IGF-1, DHEAS, and insulin to administration of rhGH, DHEA, and metformin, respectively; by frequent communication with trial volunteers; and by retrospective review of returned medication diaries. Additional follow-up blood testing was done at 18 months for cohort 1; cohort 2 was not available. In selected cases, as deemed useful, supplemental blood sampling was carried out at other times.</em></p> <p style="margin-left: 20px"></p> <p style="margin-left: 20px"><em>rhGH (Omnitrope, Sandoz) was provided to trial volunteers and was self-administered 3–4 times per week, depending on side effects, at bedtime along with other study medications. All volunteers were also provided with and asked to take supplements of 3,000 IU vitamin D3 and 50 mg of elemental zinc daily.</em></p><p></p><p>0.015mg/kg of rhGH is a pretty stiff dose. They don't specify if this was a single dose or a weekly total. For a 200lb guy this would be about a 14iu dose of rhGH. The DHEA and metformin seemed reasonable. Divided by the day 3-4 daily dose it would be about 3.4 - 4.6iu/3-4 days which is some what easier handled. I am currently doing 18iu/wk and I have been in a mental fog for weeks unable to easily stay awake up on the 2 days I do 4iu.</p><p></p><h3><p style="margin-left: 20px"><em>2.4 Epigenetic age regression</em></p> </h3> <p style="margin-left: 20px"><em>Although, on average, trial volunteer epigenetic ages (EAs) were lower than their chronological ages (As) at baseline [(EA-A)0 < 0, Table <a href="https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028#acel13028-tbl-0001" target="_blank">1</a>], epigenetic age was nevertheless significantly decreased by treatment based on the results of all four epigenetic clocks (Figure <a href="https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028#acel13028-fig-0005" target="_blank">5</a>a–d), with a mean change in EA-A after 12 months of about 2.5 years (Figure <a href="https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028#acel13028-fig-0005" target="_blank">5</a>e).</em></p> <p style="margin-left: 20px"></p> <p style="margin-left: 20px"><em>The GrimAge predictor of human morbidity and mortality showed a 2-year decrease in epigenetic vs. chronological age that persisted six months after discontinuing treatment. This is to our knowledge the first report of an increase, based on an epigenetic age estimator, in predicted human lifespan by means of a currently accessible aging intervention.</em></p> <p style="margin-left: 20px"></p> <p style="margin-left: 20px"><em> PSA, percent free PSA, and the ratio of PSA to percent free PSA, an overall index of prostate cancer risk, improved significantly by day 15 of treatment and remained favorably altered to the end of 12 months (Figure <a href="https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028#acel13028-fig-0001" target="_blank">1</a>a–c). A brief spike in PSA at 6 months in two volunteers was rapidly reversed and, after volunteer consultation, was interpreted as reflecting sexual activity close to the time of PSA testing. No change in testosterone levels was observed. </em></p></blockquote><p></p>
[QUOTE="BigTex, post: 261591, member: 43589"] Here is the study [URL unfurl="true"]https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028[/URL] Dosing [INDENT][I]During the [B]first week[/B] of the trial, [B]rhGH alone (0.015 mg/kg[/B]) was administered to obtain an initial insulin response, and during the [B]second week, rhGH was combined with 50 mg DHEA[/B] to evaluate insulin suppression by DHEA alone. During the [B]third week, the same doses of rhGH and DHEA were combined with 500 mg metformin[/B]. Beginning at the [B]fourth week, all doses were individualized based on each volunteer's particular responses[/B]. Thereafter, blood was collected one week prior to trial months 2, 3, 4, 6, and 9 to enable further dose adjustments at those time points (to maximize IGF-1 and minimize insulin), and additional blood samples were obtained at 12 months to conclude the treatment monitoring period. Dosing compliance was verified by the response of IGF-1, DHEAS, and insulin to administration of rhGH, DHEA, and metformin, respectively; by frequent communication with trial volunteers; and by retrospective review of returned medication diaries. Additional follow-up blood testing was done at 18 months for cohort 1; cohort 2 was not available. In selected cases, as deemed useful, supplemental blood sampling was carried out at other times.[/I][/INDENT] [INDENT][I][/I][/INDENT] [INDENT][I]rhGH (Omnitrope, Sandoz) was provided to trial volunteers and was self-administered 3–4 times per week, depending on side effects, at bedtime along with other study medications. All volunteers were also provided with and asked to take supplements of 3,000 IU vitamin D3 and 50 mg of elemental zinc daily.[/I][/INDENT] 0.015mg/kg of rhGH is a pretty stiff dose. They don't specify if this was a single dose or a weekly total. For a 200lb guy this would be about a 14iu dose of rhGH. The DHEA and metformin seemed reasonable. Divided by the day 3-4 daily dose it would be about 3.4 - 4.6iu/3-4 days which is some what easier handled. I am currently doing 18iu/wk and I have been in a mental fog for weeks unable to easily stay awake up on the 2 days I do 4iu. [HEADING=2][INDENT][I]2.4 Epigenetic age regression[/I][/INDENT][/HEADING] [INDENT][I]Although, on average, trial volunteer epigenetic ages (EAs) were lower than their chronological ages (As) at baseline [(EA-A)0 < 0, Table [URL='https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028#acel13028-tbl-0001']1[/URL]], epigenetic age was nevertheless significantly decreased by treatment based on the results of all four epigenetic clocks (Figure [URL='https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028#acel13028-fig-0005']5[/URL]a–d), with a mean change in EA-A after 12 months of about 2.5 years (Figure [URL='https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028#acel13028-fig-0005']5[/URL]e).[/I][/INDENT] [INDENT][/INDENT] [INDENT][I]The GrimAge predictor of human morbidity and mortality showed a 2-year decrease in epigenetic vs. chronological age that persisted six months after discontinuing treatment. This is to our knowledge the first report of an increase, based on an epigenetic age estimator, in predicted human lifespan by means of a currently accessible aging intervention.[/I][/INDENT] [INDENT][/INDENT] [INDENT][I] PSA, percent free PSA, and the ratio of PSA to percent free PSA, an overall index of prostate cancer risk, improved significantly by day 15 of treatment and remained favorably altered to the end of 12 months (Figure [URL='https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028#acel13028-fig-0001']1[/URL]a–c). A brief spike in PSA at 6 months in two volunteers was rapidly reversed and, after volunteer consultation, was interpreted as reflecting sexual activity close to the time of PSA testing. No change in testosterone levels was observed. [/I][/INDENT] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Study show’s REVERSED aging!
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top